NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin

por Yeo, Winnie, Lau, Thomas KH, Kwok, Carol CH, Lai, Kwai T, Chan, Vicky TC, Li, Leung, Chan, Vivian, Wong, Ashley, Soo, Winnie MT, Yeung, Eva WM, Wong, Kam H, Tang, Nelson LS, Suen, Joyce JS, Mo, Frankie KF
Publicado 2022